The results of the selection of four varieties of drugs purchased in Shanghai were announced, with the increase of 188% for colenfluconazole tablets

On October 11, Shanghai Sunshine pharmaceutical purchasing network announced the results of the selection of four kinds of drugs from four enterprises The purchased products are some of the products in the third batch of volume purchase catalogue that have expired It is worth noting that among the four varieties winning the bid, the price of fluconazole tablets of Kelun Pharmaceutical Co., Ltd has increased by 188%, ambroxol hydrochloride tablets of Hengrui Pharmaceutical Co., Ltd has increased by about 172% compared with last year, and the other two varieties bisoprolol fumarate tablets and glimepiride tablets have only slightly decreased The following is the original announcement: all district medical insurance bureaus, health and Family Planning Commission, designated medical institutions for medical insurance, and drug production and marketing enterprises: according to the document of Shanghai drug centralized volume purchase (Document No.: sh-dl2019-1) issued on August 19, 2019, the city has carried out centralized purchase of four varieties, and determined the results of the selection according to the procedures In accordance with the relevant requirements of the notice on the volume purchase of the third batch of medical insurance drugs in this city (Hu Ren she Yi [2018] No 226, hereinafter referred to as the notice), the bid winning results and relevant matters are hereby notified as follows: 1 The utilization of selected drugs in volume purchase is well done （1） On October 11, 2019, "Shanghai Pharmaceutical purchasing service and supervision information system" will push the information of selected drugs to all designated medical institutions of medical insurance in this city (hereinafter referred to as "medical institutions"), which will take effect on October 21 （2） 12 months from the implementation date of this selection result is a purchase cycle If the agreed purchase quantity is completed in advance within the purchase cycle, the excess part will still be purchased according to the selected price until the expiration of the purchase cycle （3） Medical institutions shall give priority to purchasing and using selected drugs with quantity, and the quantity used shall be equivalent to the level of the previous year in principle （4） Medical institutions can continue to purchase and use unselected drugs on the premise of ensuring the quantity of the selected varieties, but the quantity shall not exceed the selected varieties after being converted according to the proportion relationship 2、 To sign the tripartite purchase and sale contract in time for the selected manufacturer and the entrusted drug distribution enterprise, please sign the tripartite purchase and sale contract with Shanghai Pharmaceutical centralized bidding and Purchase Management Office (hereinafter referred to as "Shanghai Pharmaceutical office") within 10 working days after the announcement of this notice, and the funds involved in the procurement of selected drugs will be paid according to the provisions of the contract after the signing of the contract 3、 Strengthen the management of distribution, acceptance and payment collection of selected drugs in volume purchase (I) medical institutions shall purchase selected drugs in volume purchase through "sunshine platform", timely accept and confirm the invoice of centralized purchase drugs The system will take the purchase quantity of the confirmed purchased varieties with quantity as the upper limit of the purchase quantity of the unselected varieties (converted to the minimum unit) In principle, it is not allowed to return the purchased drugs with quantity (except for the return of the original vehicle or special circumstances) （2） On the 10th day of each month (holidays postponed), the municipal pharmaceutical office shall send the monthly statement of Shanghai medical insurance drug purchasing with quantity to all medical institutions, which shall be used as the accounting check instead of as the accounting voucher The statement of purchasing drugs with quantity shall be issued to the medical institutions by the municipal pharmaceutical office through the post office on a monthly basis （3） The medical institution shall prepare a payment plan based on the invoice amount of drugs purchased in the current month If the medical institution has no objection to the data and amount of the monthly statement, it shall pay off the payment before the 15th day of the month (the holiday shall be postponed) If the medical institution has any objection to the data and amount of the statement, it shall contact the distribution enterprise in a timely manner, and pay off the payment before the 15th of the next month (the holiday shall be postponed) （4） The medical institution shall give priority to purchasing and using the selected drugs with quantity, and implement the purchasing with quantity according to the quarterly and annual completion conditions indicated in the monthly statement of Shanghai medical insurance drugs with quantity, so as to ensure the stable use of relevant drugs （5） In the process of carrying out the drug purchase with quantity, the delivery enterprise must be in the same line with the bill of lading, and the "drug purchase with quantity and payment record" provided cannot be mixed with the purchase and payment records of other drugs 4、 Other matters not covered in this notice shall be implemented in accordance with the relevant documents of centralized drug purchase in Shanghai and the purchase and sale contract signed by the three parties If any problem is found in the process of purchasing and using the selected drugs, the medical institution shall timely feed back to the municipal pharmacy 5、 This notice shall come into effect on October 21, 2019 Appendix: the results of the selection of Shanghai Pharmaceutical centralized procurement with volume on October 11, 2019